Colon cancer cells acquire immune regulatory molecules from tumor-infiltrating lymphocytes by trogocytosis

Jae Hun Shin, Jaekwang Jeong, Stephen E. Maher, Heon Woo Lee, Jaechul Lim, Alfred L.M. Bothwell

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

Cancer cells can develop an immunosuppressive tumor microenvironment to control tumor-infiltrating lymphocytes. The underlying mechanisms still remain unclear. Here, we report that mouse and human colon cancer cells acquire lymphocyte membrane proteins including cellular markers such as CD4 and CD45. We observed cell populations harboring both a tumor-specific marker and CD4 in the tumor microenvironment. Sorted cells from these populations were capable of forming organoids, identifying them as cancer cells. Live imaging analysis revealed that lymphocyte membrane proteins were transferred to cancer cells via trogocytosis. As a result of the transfer in vivo, cancer cells also acquired immune regulatory surface proteins such as CTLA4 and Tim3, which suppress activation of immune cells [T. L. Walunas et al, Immunity 1, 405-413 (1994) and L. Monney et al., Nature 415, 536-541 (2002)]. RNA sequencing analysis of ex vivo-cocultured splenocytes with trogocytic cancer cells showed reductions in Th1 activation and natural killer cell signaling pathways compared with the nontrogocytic control. Cancer cell trogocytosis was confirmed in the patient-derived xenograft models of colorectal cancer and head and neck cancer. These findings suggest that cancer cells utilize membrane proteins expressed in lymphocytes, which in turn contribute to the development of the immunosuppressive tumor microenvironment.

Original languageEnglish (US)
JournalProceedings of the National Academy of Sciences of the United States of America
Volume118
Issue number48
DOIs
StatePublished - Nov 30 2021

Keywords

  • cancer
  • immune regulatory molecules
  • trogocytosis
  • tumor-infiltrating lymphocytes

ASJC Scopus subject areas

  • General

Fingerprint

Dive into the research topics of 'Colon cancer cells acquire immune regulatory molecules from tumor-infiltrating lymphocytes by trogocytosis'. Together they form a unique fingerprint.

Cite this